| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.099 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |